Chemical Structure
PD 150,606 [426821-41-2]
AG-CR1-0066
Overview
- SupplierAdipoGen Life Sciences
- Product NamePD 150,606 [426821-41-2]
- Delivery Days Customer10
- ADR Class6.1
- CAS Number426821-41-2
- CertificationResearch Use Only
- Estimated Purity>98%
- Hazard InformationDanger,Excepted quantity
- Molecular FormulaC9H7IO2S
- Molecular Weight306.1
- Scientific DescriptionCell permeable and selective calpain-1 and -2 inhibitor [1, 3]. Interacts with calcium-binding domain of calpain [2, 4]. Neuroprotective [2]. Ca2+-permeable AMPA receptor inhibitor [5]. Apoptosis inhibitor [6] Autophagy activator by preventing cleavage of ATG5 [7.] - Chemical. CAS: 426821-41-2. Formula: C9H7IO2S. MW: 306.1. Cell permeable and selective calpain-1 and -2 inhibitor. Interacts with calcium-binding domain of calpain. Neuroprotective. Ca2+-permeable AMPA receptor inhibitor. Apoptosis inhibitor Autophagy activator by preventing cleavage of ATG5
- SMILESOC(=O)C(\S)=C\C1=CC=C(I)C=C1
- Storage Instruction-20°C,2°C to 8°C
- UN NumberUN 2811
- UNSPSC12352200
References
- Modulation of hypoxia-induced calpain activity in rat renal proximal tubules: C.L. Edelstein, et al.; Kidney Int. 50, 1150 (1996)
- An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective: K.K. Wang, et al.; PNAS 93, 6687 (1996)
- Alpha-mercaptoacrylic acid derivatives as novel selective calpain inhibitors: K.K. Wang, et al.; Adv. Exp. Med. Biol. 389, 95 (1996)
- Crystal structure of calcium bound domain VI of calpain at 1.9A resolution and its role in enzyme assembly, regulation, and inhibitor binding: G.D. Lin, et al.; Nat. Struct. Biol. 4, 539 (1997)
- An alpha-mercaptoacrylic acid derivative (PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition: L. Van den Bosch, et al.; Neuropharmacology 42, 706 (2002)
- Calpain, an upstream regulator of thymocyte apoptosis: M.K. Squier & J.J. Cohen; J. Immunol. 158, 3690 (1997)
- Post-translational control of IL-1beta via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53: M. Niebler, et al.; PLoS Pathog. 9, e1003536 (2013)